Market Tracker

01/18 4:50am ET

TESARO Inc (NASDAQ:TSRO)

151.25
Delayed Data
As of Jan 17
 -5.16 / -3.30%
Today’s Change
29.51
Today|||52-Week Range
157.77
+12.47%
Year-to-Date
TESARO Varubi IV Gets Complete Response Letter in the U.S.
Jan 13 / Zacks.com - Paid Partner Content
These 3 Biotech Stocks Are Already Moving Wildly on Thursday
Jan 12 / TheStreet.com - Paid Partner Content
7 Stocks Outperforming the Market
Jan 12 / GuruFocus News - Paid Partner Content
4 Stocks in Focus as Biotech M&A Hopes Surge on Takeda-ARIAD Deal
Jan 10 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close156.41
Today’s open156.00
Day’s range150.72 - 156.49
Volume1,233,313
Average volume (3 months)1,088,349
Market cap$8.4B
Dividend yield--
Data as of 01/17/2017

Growth & Valuation

Earnings growth (last year)-33.19%
Earnings growth (this year)-16.66%
Earnings growth (next 5 years)+24.83%
Revenue growth (last year)--
P/E ratioNM
Price/Sales6,500.72
Price/Book72.52

Competitors

 Today’s
change
Today’s
% change
SGENSeattle Genetics Inc-1.40-2.37%
ALKSAlkermes Plc-0.90-1.62%
RDYDr.Reddy's Laborator...+0.12+0.28%
JAZZJazz Pharmaceuticals...-1.73-1.47%
Data as of 01/17/2017

Financials

Next reporting dateFebruary 16, 2017
EPS forecast (this quarter)-$1.95
Annual revenue (last year)$317.0K
Annual profit (last year)-$251.4M
Net profit margin-79,308.52%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Leon O. Moulder
President, Chief Operating Officer &
Director
Mary Lynne Hedley
Corporate headquarters
Waltham, Massachusetts

Forecasts